Women's Health
Women's health guidance, trial intelligence and education across reproductive health, menopause, cancer prevention and long-term conditions.
Latest Guidelines
Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopause
Fezolinetant is recommended as an option for moderate to severe vasomotor symptoms (hot flushes and night sweats) in menopausal women when hormone replacement therapy is contraindicated,…
Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management (NICE NG126)
Offer urine pregnancy test to all women presenting with abdominal pain or vaginal bleeding; proceed to transvaginal ultrasound if positive, using this as first-line imaging to…
Urinary Incontinence and Pelvic Organ Prolapse (NICE NG123)
Offer supervised pelvic floor muscle training programmes lasting at least 6 weeks as first-line treatment for stress urinary incontinence and mixed incontinence Prescribe antimuscarinics (oxybutynin, tolterodine,…
Polycystic Ovary Syndrome (NICE NG88 / RCOG Guidelines)
Diagnose PCOS using Rotterdam criteria (≥2 of: irregular periods, clinical/biochemical hyperandrogenism, or polycystic ovaries on ultrasound) after excluding other diagnoses, then assess cardiovascular risk factors (blood…
Fertility Problems: Assessment and Treatment (NICE CG156)
Offer initial fertility assessment after one year of regular unprotected intercourse, or after six months if the woman is aged 36 years or over. Confirm ovulation…
Endometriosis: Diagnosis and Management (NICE NG73)
Suspect endometriosis in women presenting with chronic pelvic pain, dysmenorrhoea, or deep dyspareunia; refer to gynaecology if symptoms persist after adequate trial of NSAIDs or hormonal…
Trial Radar
Clinical News
Evaluation of how NHS public information supports decision-making about screening tests in pregnancy
NHS public information on antenatal screening requires improvement to adequately support informed decision-making, with current materials potentially insufficient…
30 Apr 2026Women can wait years for an endometriosis diagnosis. New tech could change that
New scan technology can detect endometriosis lesions missed by conventional ultrasound and MRI, potentially reducing diagnostic delays that…
22 Apr 2026Is the calisthenics trend inclusive enough for women?
Sport England reports a 12% increase in women participating in gym-based fitness, driven partly by the calisthenics trend,…
20 Apr 2026‘My lonely start to adulthood with endometriosis’
Endometriosis diagnosis delays continue to significantly impact patients' psychological wellbeing and social development during critical life stages, highlighting…
Relevant Mechanisms
CDK4/6 Inhibition — Breast Cancer
CDK4/6 Inhibition — Breast Cancer is a clinically relevant Drug Science explainer. Cell cycle progression from G1 to S phase…
MechanismHER2 Signalling
HER2 Signalling is a clinically relevant Drug Science explainer. Human epidermal growth factor receptor 2 (HER2/ErbB2) is a receptor tyrosine…
MechanismPARP Inhibition — DNA Damage Response
PARP Inhibition — DNA Damage Response is a clinically relevant Drug Science explainer. Poly(ADP-ribose) polymerase (PARP) enzymes, principally PARP1 and…
MechanismRANKL/Bone Remodelling
RANKL/Bone Remodelling is a clinically relevant Drug Science explainer. Bone remodelling is maintained by the tightly coupled activity of osteoblasts…
CPD, Podcasts & Webinars
Follow Women's Health safety updates
Get MHRA safety alerts and clinically relevant updates for this specialty in your ClinicaliQ digest.
Follow Women's Health
Choose guideline, trial, Drug Science and education updates for this specialty.